As of close of business last night, Heart Test Laboratories Inc’s stock clocked out at $0.13, up 1.36% from its previous closing price of $0.12. In other words, the price has increased by $+0.0017 from its previous closing price. On the day, 1847358 shares were traded. HSCS stock price reached its highest trading level at $0.1349 during the session, while it also had its lowest trading level at $0.1260.
Ratios:
To gain a deeper understanding of HSCS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.32 and its Current Ratio is at 4.71. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.05.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HSCS now has a Market Capitalization of 8.69M and an Enterprise Value of 2.67M. For the stock, the TTM Price-to-Sale (P/S) ratio is 402.97 while its Price-to-Book (P/B) ratio in mrq is 0.93. Its current Enterprise Value per Revenue stands at 456.41 whereas that against EBITDA is -0.46.
Stock Price History:
Over the past 52 weeks, HSCS has reached a high of $1.49, while it has fallen to a 52-week low of $0.11. The 50-Day Moving Average of the stock is 0.1310, while the 200-Day Moving Average is calculated to be 0.4655.
Shares Statistics:
It appears that HSCS traded 3.32M shares on average per day over the past three months and 3.07M shares per day over the past ten days. A total of 63.61M shares are outstanding, with a floating share count of 53.01M. Insiders hold about 16.66% of the company’s shares, while institutions hold 1.89% stake in the company. Shares short for HSCS as of Feb 29, 2024 were 196.16k with a Short Ratio of 0.06, compared to 748.58k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.30% and a Short% of Float of 0.31%.
Earnings Estimates
As of right now, 1 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.03 for the current quarter, with a high estimate of -$0.03 and a low estimate of -$0.03, while EPS last year was -$0.21. The consensus estimate for the next quarter is -$0.04, with high estimates of -$0.04 and low estimates of -$0.04.
Analysts are recommending an EPS of between -$0.25 and -$0.25 for the fiscal current year, implying an average EPS of -$0.25. EPS for the following year is -$0.14, with 1 analysts recommending between -$0.14 and -$0.14.
Revenue Estimates
A total of 1 analysts have provided revenue estimates for HSCS’s current fiscal year. The highest revenue estimate was $100k, while the lowest revenue estimate was $100k, resulting in an average revenue estimate of $100k. In the same quarter a year ago, actual revenue was $5k, up 1,900.00% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $5.4M in the next fiscal year. The high estimate is $5.4M and the low estimate is $5.4M. The average revenue growth estimate for next year is up 5,300.00% from the average revenue estimate for this year.
